Ngo, Q.T.; Espinoza, J.L.; Li, H.; Inokuchi, M.; Nakanishi, Y.; Morishita, E.; Katagiri, T.; Kawahara, A.; Yoshizaki, T.; Takami, A.;
et al. Immunomodulatory Effects of Juzentaihoto on Fas-Mediated Apoptosis: Insights from Cancer Patients and In Vitro Models. Pharmaceuticals 2025, 18, 1658.
https://doi.org/10.3390/ph18111658
AMA Style
Ngo QT, Espinoza JL, Li H, Inokuchi M, Nakanishi Y, Morishita E, Katagiri T, Kawahara A, Yoshizaki T, Takami A,
et al. Immunomodulatory Effects of Juzentaihoto on Fas-Mediated Apoptosis: Insights from Cancer Patients and In Vitro Models. Pharmaceuticals. 2025; 18(11):1658.
https://doi.org/10.3390/ph18111658
Chicago/Turabian Style
Ngo, Quang Trung, Jorge Luis Espinoza, Hongyang Li, Masafumi Inokuchi, Yosuke Nakanishi, Eriko Morishita, Takamasa Katagiri, Akihiro Kawahara, Tomokazu Yoshizaki, Akiyoshi Takami,
and et al. 2025. "Immunomodulatory Effects of Juzentaihoto on Fas-Mediated Apoptosis: Insights from Cancer Patients and In Vitro Models" Pharmaceuticals 18, no. 11: 1658.
https://doi.org/10.3390/ph18111658
APA Style
Ngo, Q. T., Espinoza, J. L., Li, H., Inokuchi, M., Nakanishi, Y., Morishita, E., Katagiri, T., Kawahara, A., Yoshizaki, T., Takami, A., & Ogawa-Ochiai, K.
(2025). Immunomodulatory Effects of Juzentaihoto on Fas-Mediated Apoptosis: Insights from Cancer Patients and In Vitro Models. Pharmaceuticals, 18(11), 1658.
https://doi.org/10.3390/ph18111658
